Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial

PURPOSE: The adoption of hypofractionated whole-breast irradiation (HF-WBI) remains low, in part because of concerns regarding its safety when used with a tumor bed boost or in patients who have received chemotherapy or have large breast size. To address this, we conducted a randomized, multicenter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Shaitelman, Simona F., Lei, Xiudong, Thompson, Alastair, Schlembach, Pamela, Bloom, Elizabeth S., Arzu, Isidora Y., Buchholz, Daniel, Chronowski, Gregory, Dvorak, Tomas, Grade, Emily, Hoffman, Karen, Perkins, George, Reed, Valerie K., Shah, Shalin J., Stauder, Michael C., Strom, Eric A., Tereffe, Welela, Woodward, Wendy A., Amaya, Diana N., Shen, Yu, Hortobagyi, Gabriel N., Hunt, Kelly K., Buchholz, Thomas A., Smith, Benjamin D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286164/
https://ncbi.nlm.nih.gov/pubmed/30379626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados